The largest database of trusted experimental protocols

Fibroblast growth factor (fgf)

Manufactured by R&D Systems
Sourced in United States, Germany

FGF (Fibroblast Growth Factor) is a family of proteins that play a crucial role in cell growth, differentiation, and angiogenesis. This lab equipment is designed to facilitate research and analysis of FGF and its functions.

Automatically generated - may contain errors

94 protocols using fibroblast growth factor (fgf)

1

mESC and hESC Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
mESCs were a kind gift from Dr. Ihor Lemischka (Mount Sinai School of Medicine) to I.A. They were passaged and maintained on gelatin-coated dishes or in coculture with mitomycin C (MITC)-treated mouse embryo fibroblasts (MEF) (GlobalStem) in presence of LIF (ESGRO-LIF) under previously described conditions (Schaniel et al., 2009 (link)). H9 hESCs were purchased from Wicell Institute and maintained in coculture with MITC-treated MEFs in the presence of FGF (10 ng/ml; R&D) under conditions described by the supplier. hESCs were plated on Matrigel (BD Pharmingem)-coated plates in the presence of conditioned medium from MITC-treated MEFs, FGF (10 ng/ml; R&D Systems), and ROCK inhibitor (10 μM; Stemgent) for 48 hr before compound treatment to allow hESCs to resume growth following single-cell suspension with Accutase (Innovative Cell Technologies). NTERA-2 cl.D1, 293T cells were purchased from ATCC and grown under standard tissue culture conditions. Human iPSCs, a kind gift of Drs. Mark J. Tomishima and Michel Sadelain (Papapetrou et al., 2009 (link)), were cultured under standard hESC conditions. MS436 was used at 10 μM, and MS417 was used at 250 nM concentration throughout the study. DMSO was used as a vehicle control for compounds. –(+) JQ1 enantiomers were used at 500 nM concentration for 6 hr.
+ Open protocol
+ Expand
2

mESC and hESC Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
mESCs were a kind gift from Dr. Ihor Lemischka (Mount Sinai School of Medicine) to I.A. They were passaged and maintained on gelatin-coated dishes or in coculture with mitomycin C (MITC)-treated mouse embryo fibroblasts (MEF) (GlobalStem) in presence of LIF (ESGRO-LIF) under previously described conditions (Schaniel et al., 2009 (link)). H9 hESCs were purchased from Wicell Institute and maintained in coculture with MITC-treated MEFs in the presence of FGF (10 ng/ml; R&D) under conditions described by the supplier. hESCs were plated on Matrigel (BD Pharmingem)-coated plates in the presence of conditioned medium from MITC-treated MEFs, FGF (10 ng/ml; R&D Systems), and ROCK inhibitor (10 μM; Stemgent) for 48 hr before compound treatment to allow hESCs to resume growth following single-cell suspension with Accutase (Innovative Cell Technologies). NTERA-2 cl.D1, 293T cells were purchased from ATCC and grown under standard tissue culture conditions. Human iPSCs, a kind gift of Drs. Mark J. Tomishima and Michel Sadelain (Papapetrou et al., 2009 (link)), were cultured under standard hESC conditions. MS436 was used at 10 μM, and MS417 was used at 250 nM concentration throughout the study. DMSO was used as a vehicle control for compounds. –(+) JQ1 enantiomers were used at 500 nM concentration for 6 hr.
+ Open protocol
+ Expand
3

Isolation and Culture of Human ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASCs, originally isolated from the subcutaneous fat of healthy human, non-diabetic, non-smoking female donors, aged 18-60 years (N = 7), were purchased from Zen-Bio, Inc. (superlot #36; Research Triangle Park, NC). ASCs were grown in expansion medium consisting of DMEM/F-12 (HyClone), 10% FBS (Zen-Bio), 1% antibiotic/antimycotic (HyClone), 0.25 ng/mL transforming growth factor-β1, 5 ng/mL epidermal growth factor, and 1 ng/mL fibroblast growth factor (R&D Systems) (B. T. Estes, et al., 2008 (link)). ASCs were maintained in humidified incubators at 37°C, 5% CO2 and passaged at 80% confluence with 0.25% trypsin-EDTA (HyClone). Experiments used ASCs at passage 4-6 (P4-6).
NHFs derived from neonatal human foreskins (a gift from Dr. Jeffrey Morgan) were expanded in high glucose DMEM (DMEM-HG, HyClone), 10% FBS (HyClone), and 1% penicillin/streptomycin (HyClone) (Youssef, et al., 2011 (link)). Experiments used NHFs at P6-9.
+ Open protocol
+ Expand
4

Forebrain Neurosphere Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
E15.5 forebrain tissue was minced and incubated with Accutase (PAA) for 15 min at 37 °C. The cell suspension was triturated with a pipet tip, passed through a 100 µm cell strainer and centrifuged at 200 × g for 3 min. The pellet was resuspended in serum-free neurosphere proliferation medium (Dulbecco’s modified Eagle’s medium/F12 medium (Gibco) supplemented with B27 supplement (Gibco), 30 mM HEPES (Gibco), 20 ng/mL epidermal growth factor (R&D), and 20 ng/mL fibroblast growth factor (R&D)). Six days after the primary tissue isolation, cells were passaged using Accutase and cultured in neurosphere proliferation medium at a density of 105 cells/mL.
+ Open protocol
+ Expand
5

Generation of Colorectal Cancer Spheroids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Colorectal cancer derived spheroid cultures were generated from tumor tissue of two CRC patients as described earlier [27 (link)]. In brief, 2008 and 2012 primary human CRC tissue or derived metastases were obtained at the University Hospital Heidelberg in accordance with the Declaration of Helsinki. Both patients signed informed consent as approved by the Ethics Review Board of the Medical Faculty, University of Heidelberg (approval number 323–2004). The tumor samples were minced and enzymatically digested with dispase (Becton, Dickinson and Company) and DNAse I (Roche). If necessary, mucus was dissolved by sputolysin (Calbiochem). The isolated cancer cells were cultivated in ultra-low attachment flasks (Corning) under serum-free conditions with addition of 10 ng/ml fibroblast growth factor (R&D Systems) and 20 ng/ml epidermal growth factor (R&D Systems) as described previously [27 (link)]. Under these conditions, multicellular spheroids formed. These spheroid cultures were authenticated and checked for contaminations with Multiplexion [28 ]. HEK-293 T cells were cultured under the same conditions as the patient-derived CRC cells. The morphology of the cells was examined via microscope (Fluorescence microscope Axiovert 200, Zeiss).
+ Open protocol
+ Expand
6

Mouse and Human Mesenchymal Stem Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse bone marrow-derived MSCs (mMSCs) were obtained from the femoral and tibial bone marrow of 7–8 weeks old Balb/c mice as previously reported [60]. The protocols were approved by the Taipei Veterans General Hospital Institutional Animal Care and Use Committee (IACUC). All studies involving animals were in accordance with appropriate guidelines. mMSCs were maintained in Low-Glucose DMEM (LG-DMEM; Invitrogen) with 10% fetal bovine serum, and 1% PSG. Commercially available human MSCs (hMSCs) (Steminent Biotherapeutics Inc, Taipei, Taiwan) were maintained in Iscove’s modified Dulbecco’s medium (IMDM; Sigma-Aldrich), supplemented with 10% fetal bovine serum, 10 ng/ml fibroblast growth factor, 10 ng/ml epidermal growth factor (R&D systems, Inc.) and 100 U Penicillin-1000 U Streptomycin-2 mM L-glutamine (1% PSG; Sigma-Aldrich).
+ Open protocol
+ Expand
7

Cryopreserved BM-MSCs Conditioned Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved human bone marrow-derived MSC (BM-MSC) from two healthy donors were cultured in MEM-Alpha media (Gibco) supplemented with 10% extracellular vesicle (EV)-free heat-inactivated foetal calf serum (FCS) (Gibco), 1% penicillin/streptomycin (Gibco) and 1 ng/ml fibroblast growth factor (R&D Systems, Minneapolis, MN, USA). EV-free FCS was prepared by ultracentrifugation of FCS at 100,000×g (Sorvall 100SE Ultra Centrifuge) for 18 h and subsequent collection of supernatants. Culture of human corneal endothelial cells (HCEC) was carried out in DMEM supplemented with 10% FCS (Gibco) and 1% penicillin/streptomycin (Gibco). Conditioned media were prepared as described in Additional file 1: Supplementary Methods. In the case of the MSC-derived CM, this was further divided into non-manipulated CM (“MSC-CM (Whole)”) and MSC-CM from which the MSC-derived EV were depleted by ultracentrifugation for 18 h as 100,000×g (“MSC-CM (-EV)”).
+ Open protocol
+ Expand
8

Adipogenic Differentiation of ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASCs were isolated from abdomen and thigh lipoaspirate of a 56-year old, female patient with a past history of breast cancer following procedures approved by the institutional review board (IRB) of Rhode Island Hospital. Tissue was processed using previously established methods 12 (link). Prior to experiments, ASCs were expanded to third passage in medium consisting of DMEM/F-12 (Hyclone, GE Healthcare Life Sciences, Logan, UT), 10% fetal bovine serum (FBS, ZenBio, Research Triangle Park, NC), and 1% antibiotic/animycotic (Hyclone), supplemented with 5 ng/mL epidermal growth factor, 1 ng/mL fibroblast growth factor, and 0.25 ng/mL transforming growth factor-β1 (R&D Systems, Minneapolis, MN).13 (link) For differentiation experiments, ASCs were exposed to either control medium containing DMEM/F-12 with 10% FBS and 1% antibiotic/antimycotic or adipogenic medium containing control medium supplemented with 0.5 μM 3-isobutyl-1-methylxanthine (IBMX), 10 μM insulin, 200 μM indomethacin, and 1 μM dexamethasone (Sigma-Aldrich, St. Louis, MO).37 (link) Media were changed every two days.
+ Open protocol
+ Expand
9

Isolation and Differentiation of Human ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 1

Human ASCs were isolated from the stromal vascular fraction of donated human lipoaspirate, obtained from the abdomen and thigh of a single, 56-year old, female, breast cancer patient using method described in Estes, B. T. et al. Biotechnology and Bioengineering 2008, 99(4):986-995. Prior to use in examples, ASCs were passaged three times in expansion medium consisting of DMEM/F-12 (Hyclone, GE Healthcare Life Sciences, Logan, UT), 10% fetal bovine serum (FBS, ZenBio, Research Triangle Park, NC), 1% antibiotic/animycotic (Hyclone), supplemented with 5 ng/mL epidermal growth factor, 1 ng/mL fibroblast growth factor, and 0.25 ng/mL transforming growth factor-β1 (R&D Systems, Minneapolis, MN; Estes et al. 2008).

For differentiation examples, cells were exposed either to adipogenic or control (stromal) medium. Control medium consisted of DMEM/F-12 supplemented with 10% FBS, and 1% antibiotic/antimycotic. Adipogenic medium consisted of control medium supplemented with 0.5 μM 3-isobutyl-1-methylxanthine, 10 μM insulin, 200 μM indomethacin, and 1 μM dexamethasone (Sigma-Aldrich, St. Louis, MO) (Zheng et al. 2006). Media was refreshed every two days for all examples and ASC expansion.

+ Open protocol
+ Expand
10

Oris Cell Migration Assay for Asthma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Oris Cell Migration Kit was used (tebu-bio, Peterborough, United Kingdom). Triplicate repeats for vehicle control (1 μmol/L dimethyl sulfoxide), 100 nmol/L DK-PGD2 or 100 nmol/L DK-PGD2, and 1 μmol/L AZD6430 were added for 24 hours in 5 healthy control donors and 5 asthmatic donors. The concentrations of 500 nmol/L and 1 μmol/L DK-PGD2 were tested in cells from 5 healthy control donors. TGF-β1 (10 ng/mL) and fibroblast growth factor (25 ng/mL; R&D Systems) were used as positive controls in cells from 5 healthy control donors and 2 asthmatic donors. Cells were fixed and labeled with Hoechst nuclear dye (Invitrogen, Carlsbad, Calif). The number of cells migrated into the migration zone was counted by a blinded observer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!